Search
for
Sort by
Research 751–780 of 771
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Alopecia Areata: Current and Emerging Therapies
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Hair Loss in an 11-year-old
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Janus Kinase inhibitors in dermatology: a review
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects